Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-α-induced apoptosis
Open Access
- 2 February 2012
- journal article
- research article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 52 (5) , 1056-1065
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Splice variants of tissue factor promote monocyte‐endothelial interactions by triggering the expression of cell adhesion molecules via integrin‐mediated signalingJournal of Thrombosis and Haemostasis, 2011
- The VLDL receptor promotes lipotoxicity and increases mortality in mice following an acute myocardial infarctionJournal of Clinical Investigation, 2011
- Bit-1 Mediates Integrin-dependent Cell Survival through Activation of the NFκB PathwayJournal of Biological Chemistry, 2011
- Cardiomyocyte NF-κB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failureCardiovascular Research, 2010
- Pim-1 Kinase Protects Mitochondrial Integrity in CardiomyocytesCirculation Research, 2010
- Enterovirus-related activation of the cardiomyocyte mitochondrial apoptotic pathway in patients with acute myocarditisEuropean Heart Journal, 2009
- Alternatively spliced tissue factor induces angiogenesis through integrin ligationProceedings of the National Academy of Sciences, 2009
- Tissue factor/FVIIa activates Bcl-2 and prevents doxorubicin-induced apoptosis in neuroblastoma cellsBMC Cancer, 2008
- Inhibition of tissue factor signaling suppresses tumor growthBlood, 2008
- TNF-α-mediated cardiomyocyte apoptosis involves caspase-12 and calpainBiochemical and Biophysical Research Communications, 2006